Recap: Medifast Q4 Earnings
Portfolio Pulse from Benzinga Insights
Medifast (NYSE:MED) reported Q4 earnings with an EPS of $1.09, beating estimates by 13.54% but with a revenue decrease of $146.23 million from the previous year. This follows a pattern of beating EPS estimates but experiencing a share price drop the next day, as seen in the last quarter.
February 20, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Medifast reported a higher than expected Q4 EPS but saw a significant revenue drop from the previous year. Historically, beating EPS estimates has been followed by a share price drop.
Medifast's Q4 earnings beat EPS estimates, which could initially seem positive. However, the significant revenue drop and historical pattern of share price decline following earnings beats suggest a potential short-term negative impact on MED's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100